Bioventus Q3 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $142.442M Miss $149.461M Estimate

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. This is a 13.33 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $142.442 million which missed the analyst consensus estimate of $149.461 million by 4.70 percent. This is a 2.73 percent increase over sales of $138.651 million the same period last year.